RE: Break this tech down.......Thanks for all the feedback on the OTC scanner, I'm in agreement with you folks that Verisante's tech/process leads the pack.
I have been building another trade position.
Can anyone give an update/educated/experienced opinion on (spare me the "my buddy Gordo, down at Burger World says that the word on the street is.........type answers!) what is going on with the 1000 lesion study? IMO the 1000 lesion study analysis/results are more important than getting the CE Mark.
I completed a bit of reading on how health insurance companies (here in the US) handle cancer screenings, from what I learned, many more of the Insurance companies are making cancer screenings available without a co-pay or deductible (compared to 10 years ago), also many employers themselves are starting to offer free/low cost cancer screenings to employees.........IMO this trend should increase demand for Verisante's products.
Will PA's & Medical Specialists be trained to conduct Aura screenings too (not just doctors & dermatologists), will Verisante make additional profits teaching/training/certifying the Aura operators???
With the CE Mark in the bag, the published 1000 lesion study analysis/results (if outstanding) will be the catalyst for me to take a sizable longer term position. Mr Braun meets his targets.........how many trading days left in 2011???